These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

338 related items for PubMed ID: 33820450

  • 21. Development of small-molecule BRD4 degraders based on pyrrolopyridone derivative.
    Zhang J, Chen P, Zhu P, Zheng P, Wang T, Wang L, Xu C, Zhou J, Zhang H.
    Bioorg Chem; 2020 Jun; 99():103817. PubMed ID: 32361153
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Design, synthesis and biological evaluation of novel 6-phenyl-1,3a,4,10b-tetrahydro-2H-benzo[c]thiazolo[4,5-e]azepin-2-one derivatives as potential BRD4 inhibitors.
    Li Q, Li J, Cai Y, Zou Y, Chen B, Zou F, Mo J, Han T, Guo W, Huang W, Qiu Q, Qian H.
    Bioorg Med Chem; 2020 Aug 01; 28(15):115601. PubMed ID: 32631570
    [Abstract] [Full Text] [Related]

  • 24. Identification of a Series of N-Methylpyridine-2-carboxamides as Potent and Selective Inhibitors of the Second Bromodomain (BD2) of the Bromo and Extra Terminal Domain (BET) Proteins.
    Harrison LA, Atkinson SJ, Bassil A, Chung CW, Grandi P, Gray JRJ, Levernier E, Lewis A, Lugo D, Messenger C, Michon AM, Mitchell DJ, Preston A, Prinjha RK, Rioja I, Seal JT, Taylor S, Wall ID, Watson RJ, Woolven JM, Demont EH.
    J Med Chem; 2021 Aug 12; 64(15):10742-10771. PubMed ID: 34232650
    [Abstract] [Full Text] [Related]

  • 25. Structure-guided discovery of novel potent and efficacious proteolysis targeting chimera (PROTAC) degrader of BRD4.
    Xiang W, Wang Q, Ran K, Ren J, Shi Y, Yu L.
    Bioorg Chem; 2021 Oct 12; 115():105238. PubMed ID: 34390970
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Design, synthesis, and biological evaluation of novel 4,4-difluoro-1-methyl-N, 6-diphenyl-5, 6-dihydro-4H-pyrimido [4, 5-b] [1, 2, 4] triazolo [4, 3-d] [1, 4] diazepin-8-amine derivatives as potential BRD4 inhibitors.
    Li J, Zhang W, Qiu Q, Zhou D, Feng Z, Tong Z, Wei J, Huang W, Li J, Qian H, Shi W.
    Chem Biol Drug Des; 2021 May 12; 97(5):1117-1128. PubMed ID: 33638254
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Crystal structure of [1,2,4]triazolo[4,3-b]pyridazine derivatives as BRD4 bromodomain inhibitors and structure-activity relationship study.
    Kim JH, Pandit N, Yoo M, Park TH, Choi JU, Park CH, Jung KY, Lee BI.
    Sci Rep; 2023 Jul 04; 13(1):10805. PubMed ID: 37402749
    [Abstract] [Full Text] [Related]

  • 35. Discovery, X-ray Crystallography, and Anti-inflammatory Activity of Bromodomain-containing Protein 4 (BRD4) BD1 Inhibitors Targeting a Distinct New Binding Site.
    Liu Z, Li Y, Chen H, Lai HT, Wang P, Wu SY, Wold EA, Leonard PG, Joseph S, Hu H, Chiang CM, Brasier AR, Tian B, Zhou J.
    J Med Chem; 2022 Feb 10; 65(3):2388-2408. PubMed ID: 34982556
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Novel inhibitors of bromodomain and extra-terminal domain trigger cell death in breast cancer cell lines.
    Rahnasto-Rilla M, Puumalainen T, Karttunen V, Adla SK, Lahtela-Kakkonen M.
    Bioorg Med Chem; 2024 Oct 01; 112():117884. PubMed ID: 39226716
    [Abstract] [Full Text] [Related]

  • 39. Fragment-based drug discovery of 2-thiazolidinones as BRD4 inhibitors: 2. Structure-based optimization.
    Zhao L, Wang Y, Cao D, Chen T, Wang Q, Li Y, Xu Y, Zhang N, Wang X, Chen D, Chen L, Chen YL, Xia G, Shi Z, Liu YC, Lin Y, Miao Z, Shen J, Xiong B.
    J Med Chem; 2015 Feb 12; 58(3):1281-97. PubMed ID: 25559428
    [Abstract] [Full Text] [Related]

  • 40. Development of photocontrolled BRD4 PROTACs for tongue squamous cell carcinoma (TSCC).
    Li Z, Ma S, Yang X, Zhang L, Liang D, Dong G, Du L, Lv Z, Li M.
    Eur J Med Chem; 2021 Oct 15; 222():113608. PubMed ID: 34119833
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.